Quest Diagnostics, Inc. (DGX)


Stay up to date

quest diagnostics (nyse: dgx) empowers people to take action to improve health outcomes. derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. quest annually serves one in three adult americans and half the physicians and hospitals in the united states, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. the company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (ap) services, & interpretive consultation through its medical & scientific staff of about 900 m.d.s & ph.d.s. the company reported 2014 revenues of $7.4 billion. quest diagnostics offers the most extensive clinical testing network in the u.s., with laborator

Financial Statements

Key Info

  • Industry:
  • Sector:
  • CEO Name: Stephen Rusckowski

Key Statistics

  • Stock Price: $138.18
  • Dividend Yield: 2.0%
  • Market Capitalization: $15,497,274,573
  • Shares Outstanding: 111,091,574
  • Number of Employees: 25,064
  • Trailing 12-Month EPS: $7.47
  • Trailing 12-Month DPS: $2.86
  • Payout Ratio: 38.3%

Important Dates

  • Next Earnings Date: 2024-07-25
  • Next Ex-Dividend Date: 2024-04-05

Price Trends

  • Current Stock Price: $138.18
  • 52-week high: $143.16
  • 52-week low: $117.6
  • 200-day moving average: $130.42
  • 50-day moving average: $130.43


  • 1-Month Price Return: 5.4%
  • 3-Month Price Return: 8.5%
  • 6-Month Price Return: 10.5%
  • 1-Year Price Return: 2.7%
  • 2-Year Price Return: 8.7%
  • 5-Year Price Return: 60.5%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast